Aptadel Therapeutics
www.aptadeltx.comAptadel Therapeutics is a preclinical-stage biotech company located in Barcelona, Spain. We are developing an RNA-based delivery platform for cancer treatment. The platform is based on Aptamer technologies. Our lead indication is Ewing Sarcoma, a rare variety of bone cancer, affecting children.
Read moreAptadel Therapeutics is a preclinical-stage biotech company located in Barcelona, Spain. We are developing an RNA-based delivery platform for cancer treatment. The platform is based on Aptamer technologies. Our lead indication is Ewing Sarcoma, a rare variety of bone cancer, affecting children.
Read moreCountry
City (Headquarters)
Barcelona
Industry
Employees
1-10
Founded
2020
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Scientific Officer / Chief Operations Officer and Co - Founder
Email ****** @****.comPhone (***) ****-****
Reach decision makers at Aptadel Therapeutics
Free credits every month!
Aptadel Therapeutics FAQ
Barcelona, Spain
Biotechnology Research